neratinib - Robuta Search

https://www.diabetes.co.uk/news/2019/Nov/cancer-drug-neratinib-offers-hope-for-type-1-diabetes-treatment.html

Cancer drug neratinib offers hope for type 1 diabetes treatment

A drug used to treat breast cancer, neratinib, has the potential to halt the immune system from destroying beta cells in type 1 diabetes.

cancer drug diabetes treatment neratinib offers hope

https://www.pharmaceutical-technology.com/data-insights/neratinib-puma-biotechnology-human-epidermal-growth-factor-receptor-2-negative-breast-cancer-her2-breast-cancer-likelihood-of-approval/

Neratinib by Puma Biotechnology for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer...

Neratinib is under clinical development by Puma Biotechnology and currently in Phase II for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer...

epidermal growth factor puma biotechnology neratinib human receptor

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-neratinib-extended-adjuvant-treatment-early-stage-her2-positive-breast-cancer

FDA approves neratinib for extended adjuvant treatment of early stage HER2-positive breast cancer |...

adjuvant treatment early stage fda neratinib extended

https://www.pharmaceutical-technology.com/data-insights/neratinib-puma-biotechnology-ovarian-cancer-likelihood-of-approval/

Neratinib by Puma Biotechnology for Ovarian Cancer: Likelihood of Approval

Neratinib is under clinical development by Puma Biotechnology and currently in Phase I for Ovarian Cancer.

puma biotechnology ovarian cancer neratinib likelihood approval